“Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis” (2022) Farmeconomia. Health economics and therapeutic pathways, 23(1). doi:10.7175/fe.v23i1.1532.